Delivery Order SPE2DX22D0010-SPE2D825FHF39

This delivery order, awarded on July 28, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,433.04 with a firm fixed price structure, was issued through the Medical Supply Chain to support federal medical procurement needs. The contract is not set-aside and was competitively awarded to AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, with performance occurring at the company's corporate office location. The funding originates from the Defense agency through the DLA Medical Supply Chain, reflecting the government's reliance on AmerisourceBergen as a critical pharmaceutical and medical supply vendor for military and veteran healthcare systems.

AmerisourceBergen's role under this delivery order aligns with its substantial $999.9 billion prime IDC with DLA Troop Support Medical, which runs through December 2026 and enables the company to supply comprehensive pharmaceutical products and medical supplies globally. This particular delivery order represents one transaction within the company's extensive federal contract portfolio, which encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The contract structure and AmerisourceBergen's positioning as a preferred pharmaceutical supplier demonstrate the company's capability to meet federal procurement requirements for medical support across Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems.